ARID4A: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:51, 17 March 2025
ARID4A (AT-rich interaction domain 4A) is a protein that in humans is encoded by the ARID4A gene. This protein is a key component of the histone deacetylase complex, which plays a crucial role in the regulation of gene expression.
Function[edit]
The ARID4A protein is part of the mSin3A family of histone deacetylase complexes, which are involved in the transcriptional repression of genes. This protein contains two AT-rich interaction domains (ARID), which are responsible for binding to AT-rich regions of DNA. The ARID4A protein also contains a chromodomain, which is involved in the recognition of histone modifications.
Clinical significance[edit]
Mutations in the ARID4A gene have been associated with various types of cancer, including breast cancer and ovarian cancer. The ARID4A protein is thought to act as a tumor suppressor, and loss of its function can lead to uncontrolled cell growth and tumorigenesis.
Research[edit]
Research into the role of ARID4A in cancer is ongoing, with studies investigating its potential as a biomarker for cancer diagnosis and prognosis, as well as a target for cancer therapy.
See also[edit]
References[edit]
<references group="" responsive="1"></references>

